CREBBP is one of the most frequently mutated genes in DLBCL and acts as a tumor suppressor of germinal center-derived lymphomagenesis by promoting transcription, counteracting the inhibition of B-cell lymphoma 6 (BCL6) [44]. Here, BCL6 is linked to neoplasm.